Vorapaxar
- Generic Name
- Vorapaxar
- Brand Names
- Zontivity
- Drug Type
- Small Molecule
- Chemical Formula
- C29H33FN2O4
- CAS Number
- 618385-01-6
- Unique Ingredient Identifier
- ZCE93644N2
- Background
Vorapaxar is a tricyclic himbacine-derived selective inhibitor of protease activated receptor (PAR-1) indicated for reducing the incidence of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease (PAD). By inhibiting PAR-1, a thrombin receptor expressed on platelets, vorapaxar prevents t...
- Indication
Vorapaxar is indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). It is usually co-administered with acetylsalicylic acid (ASA) and/or clopidogrel, and should therefore be administered as an addition to these medications as it has not been studied alone.
- Associated Conditions
- Cardiovascular Events
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.